1,001 results on '"Panteghini, Mauro"'
Search Results
2. Association of maternal folate and B12 vitamin status with gestational diabetes mellitus: Still an open issue
3. Incidence and status of insulin secretion in pregnant women with flat plasma glucose profiles during oral glucose tolerance test
4. Laboratory investigation of peritoneal fluids: an updated practical approach based on the available evidence.
5. Sources and clinical significance of aspartate aminotransferase increases in COVID-19
6. Impact of managing affected results in haemolysed samples of an infant-maternity hospital using an unconventional approach
7. Is pre-biopsy serum prostate specific antigen retesting always justified? A study of the influence of individual and analytical factors on decision making for biopsy referral
8. Analytical performance specifications for combined uncertainty budget in the implementation of metrological traceability.
9. State-of-the-art model for derivation of analytical performance specifications: how to define the highest level of analytical performance technically achievable.
10. What the Milan conference has taught us about analytical performance specification model definition and measurand allocation.
11. Analytical performance specifications – moving from models to practical recommendations.
12. An improved implementation of metrological traceability concepts is needed to benefit from standardization of laboratory results.
13. A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity
14. Time to refresh and integrate the JCTLM database entries for total bilirubin: the way forward.
15. Procalcitonin: Between evidence and critical issues
16. APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data.
17. Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up
18. Measurement uncertainty: Friend or foe?
19. Defining permissible limits for the combined uncertainty budget in the implementation of metrological traceability
20. The role of external quality assessment in the verification of in vitro medical diagnostics in the traceability era
21. An outline of measurement uncertainty of total protein in urine estimated according to the ISO Technical Specification 20914.
22. Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results
23. Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants
24. The role of laboratory in ensuring appropriate test requests
25. Total laboratory automation: Do stat tests still matter?
26. Documenting and validating metrological traceability of serum alanine aminotransferase measurements: a priority for medical laboratory community for providing high quality service in hepatology.
27. Validation of metrological traceability of the new generation of Abbott Alinity alkaline phosphatase assay.
28. Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease.
29. Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing Schemes.
30. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study
31. Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs.
32. Evaluating and monitoring analytical quality by internal quality control
33. Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study
34. Recommendations for Setting a Criterion for Assessing Commutability of Secondary Calibrator Certified Reference Materials.
35. Current performance of C-reactive protein determination and derivation of quality specifications for its measurement uncertainty.
36. C-reactive protein and clinical outcome in COVID-19 patients: the importance of harmonized measurements.
37. Role and responsibilities of laboratory medicine specialists in the verification of metrological traceability of in vitro medical diagnostics
38. State of the art of measurement uncertainty of serum ferritin.
39. Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
40. Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference
41. Fast track protocols using highly sensitive troponin assays for ruling out and ruling in non-ST elevation acute coronary syndrome
42. The laboratory investigation of pleural fluids: An update based on the available evidence.
43. Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system
44. Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases”
45. Estimation of the reference interval for serum folate measured with assays traceable to the WHO International Standard
46. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes
47. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
48. Progress and impact of enzyme measurement standardization
49. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department
50. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.